From Idea to Income: Navigating the Chinese PCT National Phase with the Slimming Strategy
When an inventor files a PCT application, the instinct is always to go broad — claim everything you can while the window is open. That instinct is not wrong. But there's a moment, usually around month 28 or 29, when you have to make a very practical decision about China. Do you enter the Chinese national phase with your full PCT claim set — or do you slim it down first? This is a question I've helped hundreds of foreign founders and IP teams navigate. And the right answer almost always involves what I call the slimming strategy. Why China's National Phase Is Different China's China Patent system is built on a "first to file" principle, and CNIPA processes a staggering volume of applications — nearly half of all PCT national phase entries globally. That volume means the system has developed detailed, and sometimes strict, fee structures. Here's the key cost driver most applicants miss: China charges extra official fees for each claim beyond the tenth. If your PCT application entered with 25 claims, you're paying surcharges on 15 of them — before you've even had a single substantive examination. That's not the only cost lever. You're also paying for translation of your entire application into Chinese, typically at a per-character or per-word rate. A long, broad specification with dozens of unnecessary claims multiplies at every step. What the Slimming Strategy Actually Means The slimming strategy is not about giving up protection. It's about entering China with a claim set tailored to what the Chinese market actually needs to protect. Here are the three steps I walk clients through: 1. Audit your claims for China relevance. A US or EU patent may have claims covering specific regulatory contexts, component configurations, or use cases that don't exist in the Chinese market. Strip those before national phase entry. They add cost without adding value. 2. Reduce claim count to 10 or below where possible. If you can consolidate dependent claims without losing core protection, do it before filing the Chinese translation. Every claim above 10 triggers an additional fee at CNIPA. 3. Sharpen your independent claims for the Chinese enforcement context. In China, the enforceability of a patent often comes down to one or two independent claims. Make them tight, clear, and commercially relevant. Abstract claims that might survive in Europe often fail or become unenforceable in Chinese courts. The Right Time to Slim This is critical: you must make slimming amendments before or at the time of national phase entry, typically by the 30-month deadline from your priority date. Amending claims after entering national phase is possible but triggers additional examination rounds and costs. Under PCT Article 19, you can amend claims at the international phase before entering China. Use that window. Work with a China Patent Attorney who understands both Chinese patent law and the commercial context of your product. What Founders Often Get Wrong I see two common mistakes: Mistake 1: Entering with the full PCT claim set to "keep options open." This is expensive and tactically weak. You're paying to protect claims you'll likely never enforce, and bloating your specification makes Chinese examination slower and more contentious. Mistake 2: Slimming too aggressively. Some applicants, trying to cut costs, drop claims they'll later need — especially around manufacturing methods or component-level protection. If copycats are your main risk in China, you often need both product and method claims. The balance point depends on your industry, your enforcement likelihood, and your budget horizon. From Idea to Income: Why Claim Quality Beats Claim Quantity The title of this article uses the word "income" deliberately. A Chinese patent that exists on paper but is never enforced, never licensed, and never cited in a deal is not generating income — it's generating filing fees. Practically, a well-slimmed Chinese patent has immediate commercial value in three situations: Licensing negotiations. When a Chinese manufacturer or distributor is assessing whether to take a license, they want clean, narrow claims — not a sprawling set that a good lawyer can pick apart. A 10-claim application with two irrefutable independent claims is worth more in a licensing meeting than a 30-claim application that invites dispute. Investment due diligence. Foreign investors and acquirers looking at your China market position will assess your registered IP. Clear claim scope with a clean prosecution history signals that the patent was filed with enforcement in mind. Distributing exclusivity. If you want to appoint an exclusive distributor in China, a slimmed, granted patent with specific product claims gives that distributor something real to enforce against copycats. If you're approaching your 30-month deadline and haven't yet thought through your China entry strategy, that conversation needs to happen now — not after CNIPA acknowledges your filing.Need help choosing the right China patent entry strategy? Explore our China Patent services or speak with a China Patent Attorney to plan your national phase entry the right way.
